Skin cancers in renal-transplant recipients occur more frequently than previously recognized in a temperate climate

Transplantation

Volumn 77, Issue 4, 2004, Pages 574-579

  Bordea, Cristina ^a,d   Wojnarowska, F ^b   Millard, P R ^a   Doll, H ^c   Welsh, K ^b   Morris, P J ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b CHURCHILL HOSPITAL   (United Kingdom)

^c IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^d BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; STEROID;

ADULT; AGE; AGED; BASAL CELL CARCINOMA; CANCER INCIDENCE; CANCER MORTALITY; CLIMATE; CONTROLLED STUDY; EUROPE; FEMALE; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KERATOACANTHOMA; KIDNEY TRANSPLANTATION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; MERKEL CELL TUMOR; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEBACEOUS CARCINOMA; SKIN CANCER; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; CLIMATE; HUMANS; INCIDENCE; KIDNEY TRANSPLANTATION; LYMPHATIC METASTASIS; MULTIVARIATE ANALYSIS; SKIN NEOPLASMS;

EID: 1442311442     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000108491.62935.DF     Document Type: Review

References (25)

1. Walder B, Robertson M, Jeremy D. Skin cancer and immunosuppression. Lancet 1971; 2: 1282.
2. Bouwes Bavinck JN, Hardie DR, Green A, et al. The risk of skin cancer in transplant patients in Queensland, Australia. Transplantation 1996; 61(5): 715.
3. Hartevelt MM, Bouwes Bavinck JN, Kootte AMM, et al. Incidence of skin cancer after transplantation in The Netherlands. Transplantation 1990; 49(3): 506.
4. Ramsey H, Fryer A, Hawley C, al e. Non-melanoma skin cancer risk in the Queensland transplant population. Br J Dermatol 2002; 147: 950.
5. Penn I. Occurrence of cancers in immunosuppressed organ transplant recipients. In: Cecka Ta, ed. Clinical transplants. Los Angeles, UCLA Tissue Typing Laboratory 1994, pp 99-109.
6. Gooptu C, Woollons A, Ross J, et al. Merkel cell carcinoma arising after therapeutic immunosuppression. Br J Dermatol 1997; 137: 637.
7. Blohme I, Larko O. Skin lesions in renal transplant patients after 10-23 years of immunosuppressive therapy. Acta Derm Venereol (Stockh) 1990; 70: 491.
8. Whittam LR, Coleman R, MacDonald DM. Plasma cell tumour in a renal transplant recipient. Clin Exp Dermatol 1996; 21: 367.
9. Sheil AGR, Disney APS, Mathew TG, et al. Malignancy following renal transplantation. Transplantation Proc 1992; 24(5): 1946.
10. Liddington M, Richardson AJ, Higgins RM, et al. Skin cancer in renal transplant recipients. Br J Surg 1989; 76(10): 1002.
11. London NJ, Farmery SM, Will EJ, et al. Risk of neoplasia in renal transplant patients. Lancet 1995; 346(8972): 403.
12. Ferrandiz C, Fuente MJ, Ribera M, et al. Epidermal dysplasia and neoplasia in kidney transplant recipients. J Am Acad Dermatol 1995; 33: 590.
13. Sheil AG, Disney AP, Mathew TH, et al. De novo malignancy emerges as a major cause of morbidity and late failure in renal transplantation. Transplant Proc 1993; 25(1 pt 2): 1383.
14. Glover MT, Niranjan N, Kwan JT, et al. Non-melanoma skin cancer in renal transplant recipients: the extent of the problem and a strategy for management. Br J Plast Surg 1994; 47(2): 86.
15. McLelland J, Rees A, Williams G, et al. The incidence of immunosuppression-related skin disease in long-term transplant patients. Transplantation 1988; 46(6): 871.
16. Brown JH, Hutchinson T, Kelly AM, et al. Dermatologic lesions in a transplant population. Transplantation 1988; 46: 530.
17. Hepburn DJ, Divakar D, Bailey RR, et al. Cutaneous manifestations of renal transplantation in a New Zealand population. N Z Med J 1994; 107(991): 497.
18. Bordea C, Wojnarowska F, Morris PJ. Multiple cutaneous malignancies arising in limbs with signs of lymphatic insufficiency in transplant patients. Br J Plast Surg 1999; 52: 619.
19. Ko CB, Walton S, Keczkes K, et al. The emerging epidemic of skin cancer. Br J Dermatol 1994; 130: 269.
20. Penn I. Cancers following cyclosporine therapy. Transplantation 1987; 43(1): 32.
21. Aubry F, MacGibbon B. Risk factors of squamous cell carcinoma of the skin. A case-control study in the Montreal region. Cancer 1985; 55(4): 907.
22. Karagas MR, Stukel TA, Greenberg ER, et al. Risk of subsequent basal cell carcinoma and squamous cell carcinoma of the skin among patients with prior skin cancer. JAMA 1992; 267(24): 3305.
23. Disney AP, Russ GR, Walker R, et al. ANZDATA registry report 1997. Adelaide, South Australia, Australia and New Zealand Transplant Registry 1997.
24. Marshall SE, Bordea C, Haldar NA, et al. Glutathione S-transferase polymorphisms and skin cancers after renal transplantation. Kidney Int 2000; 58: 2186.
25. Ramsey H, Harden P, Reece S, et al. Polymorphisms in glutathione S-transferases are associated with altered risk of non-melanoma skin cancer in renal transplant recipients: a preliminary analysis. J Invest Dermatol 2001; 117 (2): 251.